Active Constituent(s)
92.2 g/kg Cefuroxime Sodium
Indications
Treatment of clinical mastitis in milking cows caused by Staphylococcus spp., Staphylococcus aureus (including penicillin resistant strains), Streptococcus agalactiae, Streptococcus. dysgalactiae, Streptococcus. uberis, Escherichia coli, Enterobacter spp., Klebsiella spp., Citrobacter spp., Corynebacteria spp. (including Arcanobacterium pyogenes) and Micrococcus spp.
Maxalac L.C. is therefore suitable for treatment of clinical mastitis caused by all the major mastitis pathogens.
Dosage
| Apply one syringe to each infected quarter every 12 hours for 3 treatments. |
|---|
| After milking is complete, clean and disinfect the teat with an approved teat disinfectant, and ensure the teat end is dry. Wear clean rubber gloves when applying. Insert the nozzle fully into the teat canal and apply gentle and continuous pressure on the plunger until all the suspension is expressed. Holding the end of the teat in one hand, gently massage upwards with the other to aid dispersion of the antibiotic into the quarter. Dip all teats into an approved teat disinfectant after infusion. |
Withholding Period(s)
Milk: Milk taken from cows within 72 hours (6 milkings) following last treatment MUST NOT BE USED for human consumption or supplied for processing. This milk should not be fed to bobby calves.
Meat: DO NOT USE within 7 days of slaughter for human consumption.
Trade Advice (ESI)
Export Slaughter Interval
This product does not have an ESI established. For advice on the ESI, contact Jurox Pty Ltd on 1800 023 312 before using this product.
Product Codes
| Size | Code |
|---|---|
| 20's | 503205 |